PolyPeptide Group Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PolyPeptide Group's estimated annual revenue is currently $267.7M per year.(i)
  • PolyPeptide Group's estimated revenue per employee is $201,000

Employee Data

  • PolyPeptide Group has 1332 Employees.(i)
  • PolyPeptide Group grew their employee count by 6% last year.

PolyPeptide Group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Production - Down StreamReveal Email/Phone
3
Head ProductionReveal Email/Phone
4
Head Program ManagementReveal Email/Phone
5
Head ManufacturingReveal Email/Phone
6
Head Analytical DevelopmentReveal Email/Phone
7
Head Project Management DepartmentReveal Email/Phone
8
Head - Quality at PolyPeptide GroupReveal Email/Phone
9
Quality Assurance OfficerReveal Email/Phone
10
Head Manufacturing & Supply ChainReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is PolyPeptide Group?

PolyPeptide Laboratories specializes in developing small- and large-scale production processes for proprietary peptides. Whether you require gram or multi-kilogram quantities, we can support your custom project at every step, even with the most complex peptides. The evidence is in our track record, with hundreds of successful projects over the years.

keywords:N/A

N/A

Total Funding

1332

Number of Employees

$267.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PolyPeptide Group News

2022-04-20 - Peptide Therapeutics Market Report 2022, COVID-19 Impact ...

... Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited and Teva ... Novo Nordisk A/S; PolyPeptide Group; CordenPharma International.

2022-04-20 - Global Peptide Therapeutics Market Rise in Demand ...

... Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited and ... Novo Nordisk A/S; PolyPeptide Group; CordenPharma International;...

2022-04-20 - PolyPeptide Group announces results of the annual General Meeting 2022

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by...

2021-06-25 - PolyPeptide : appoints Christina Del Vecchio as General Counsel and member of the Executive Committee

EQS Group-Ad-hoc: PolyPeptide Group / Key word(s): Personnel PolyPeptide Group appoints Christina Del Vecchio as General Counsel and member of the Executive Committee 25-Jun-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for th ...

2021-04-21 - PolyPeptide : launches IPO on the Swiss Stock Exchange and sets price range at CHF 57 to CHF 68 per share

EQS Group-News: PolyPeptide Group / Key word(s): IPO PolyPeptide Group launches IPO on the Swiss Stock Exchange and sets price range at CHF 57 to CHF 68 per share 21.04.2021 / 07:00 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M13438%N/A
#2
$512.6M13569%N/A
#3
$197.2M13815%N/A
#4
$254.6M13993%N/A
#5
$200.8M14068%N/A